Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1

Interventions

Paclitaxel 41 Specimen Handling 36 Carboplatin 34 pembrolizumab 32 Bevacizumab 32 Magnetic Resonance Spectroscopy 29 olaparib 19 liposomal doxorubicin 16 Cisplatin 16 Biopsy 16 Gemcitabine 15 Taxes 12 Nivolumab 12 Immunoglobulin G 11 Disulfides 11 Cyclophosphamide 11 Topotecan 10 Doxorubicin 10 fludarabine 9 niraparib 7 mirvetuximab soravtansine 7 Fulvestrant 7 trastuzumab deruxtecan 6 palbociclib 6 durvalumab 6 Surveys and Questionnaires 6 Megestrol Acetate 6 lenvatinib 5 dostarlimab 5 Radiation 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

tisotumab vedotin × Gynecologic × 30 days × Clear all

NCT06459180 2026-05-27

TroFuse-020

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡